Skip to main content

Star Health & Allied Insurance Company Ltd

NSE: STARHEALTH BSE: 543412Finance

Star Health & Allied Insurance Ltd (Star) is India’s first Standalone Health Insurance provider and is the largest private health insurer in India with a market share of 15.8% in the Indian health insurance market in FY21 with leadership in the attractive retail health segment.[1]

496
52W: ₹413 — ₹587
PE 52.4 · Book ₹163 · +204% vs book
Market Cap₹29,188 Cr
Stock P/E52.4Price to Earnings
ROCE8.57%Return on Capital
ROE6.7%Return on Equity
Div. Yield0%Face Value ₹10

Strengths

  • +Company is almost debt free.

Weaknesses

  • Stock is trading at 3.06 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 9.66% over last 3 years.

Shareholding Pattern

Promoters57.98%
FIIs15.06%
DIIs20.31%
Public6.66%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters57.9%57.7%0.257.68%0.057.67%0.058.04%0.458.03%0.057.98%0.157.98%
FIIs21.58%17.65%3.917.51%0.118.69%1.213.89%4.813.51%0.414.07%0.615.06%1.0
DIIs15.1%17.05%2.016.49%0.615.44%1.021.08%5.621.09%0.020.96%0.120.31%0.7
Public5.4%7.6%2.28.32%0.78.22%0.16.97%1.37.38%0.46.99%0.46.66%0.3

Financial Statements

MetricDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales3,5783,6883,8164,0584,1464,0814,2334,3784,5664,648
Expenses3,1913,5023,3913,9123,8614,0893,8824,3034,3954,500
Operating Profit387186425147285-735175172148
OPM %11%5%11%4%7%0%8%2%4%3%
Net Profit290142319111215126355128111
EPS ₹4.952.435.451.893.660.014.470.932.181.89

AI Insights

Revenue Trend

Mar 2026 revenue at ₹17,825Cr, up 10.7% YoY. OPM at 4%.

Debt Position

Borrowings at ₹490Cr. Debt-to-equity ratio: 0.05x. Healthy balance sheet.

Institutional Flow

DIIs: 20.31% (+17.23pp change). FIIs: 15.06% (-18.03pp change). Promoters hold 57.98%.

Margin & Efficiency

ROCE improving from 0% (Mar 2015) to 9% (Mar 2026). Working capital days: -44.

Valuation

PE 52.4x with 8.57% ROCE. Price is 204% above book value of ₹163. Dividend yield: 0%.

Recent Announcements